Verapamil Hydrochloride

CAS 152-11-4 11 current records 10 historicalSmall Molecule

Who holds supplier records for Verapamil Hydrochloride? 11 organisations hold a current record for Verapamil Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), Italy (2), USA (1) and Netherlands (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Verapamil Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/verapamil-hydrochloride

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    7 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Verapamil Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Verapamil Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Verapamil Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
AURORE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2019-172 - Rev 02
Verapamil hydrochloride
Jul 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2018-204 - Rev 03
Verapamil hydrochloride
Apr 2026—
ASSURGEN PHARMA PRIVATE LIMITED VisakhapatnamIN
CEP 2019-014 - Rev 03
Verapamil hydrochloride
Apr 2026Inspected May 2023
Hungary, outside 3-year window
PIRAMAL PHARMA LIMITED Digwal VillageIN
CEP 2005-141 - Rev 07
Verapamil hydrochloride
Mar 2026Inspected Jun 2025
Netherlands
TAPI NL B.V. AmsterdamNL
CEP 2006-098 - Rev 04
Verapamil hydrochloride
Mar 2025—
COHANCE LIFESCIENCES LIMITED HyderabadIN
R0-CEP 2020-022 - Rev 01
Verapamil hydrochloride
Dec 2022—
Recordati S.p.A. MilanoIT
R1-CEP 2001-136 - Rev 03
Verapamil hydrochloride
Jan 2012—
ABBOTT LABORATORIES Abbott ParkUS
R1-CEP 1997-132 - Rev 04
Verapamil hydrochloride
Oct 2009—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (10)

Organisations whose Type II DMFs for Verapamil Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 10 historical records
  • India · Inactive DMF 18523 · filed Jul 2005
  • CHEMISCHE FABRIK WEYL GMBH
    Inactive DMF 7455 · filed Apr 1988
  • ALFA CHEMICALS ITALIANA SRL
    Inactive DMF 7244 · filed Nov 1987
  • SIBEFAT SPA
    Inactive DMF 6708 · filed Nov 1986
  • CHINOIN PHARMACEUTCIAL AND CHEMICAL WORKS CO LTD
    Inactive DMF 6208 · filed Jan 1986
  • SELOC AG
    Inactive DMF 5564 · filed Oct 1984
  • DINAMITE DIPHARMA SPA
    Inactive DMF 5420 · filed May 1984
  • GANES CHEMICALS INC PENNSVILLE DIV
    Inactive DMF 5227 · filed Dec 1983
  • South Africa · Inactive DMF 5141 · filed Nov 1983
  • OMNICHEM NV
    Inactive DMF 4817 · filed Feb 1983

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Verapamil Hydrochloride is a calcium channel blocker used primarily for the treatment of hypertension, angina, and certain types of arrhythmias. It relaxes and widens blood vessels, improving blood flow and reducing the workload on the heart.

Chemical identity

IUPAC name
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride
Canonical SMILES
CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl
InChIKey
DOQPXTMNIUCOSY-UHFFFAOYSA-N
Synonyms
Calan API, calan, covera, isoptin, lu-20175, nsc-272366, nsc-657799, tarka component verapamil hydrochloride, verapamil hcl, verapamili hydrochloridum, verelan

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Calcium Channel Blocker
Mechanism of action
Calcium Channel Antagonists; Cytochrome P450 3A Inhibitors; Cytochrome P450 3A4 Inhibitors; P-Glycoprotein Inhibitors

Therapeutic areas

CardiovascularHypertensionAngina

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Verapamil Hydrochloride?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Verapamil Hydrochloride: Abbott Laboratories (USA), Aurore Life Sciences (India), COHANCE LIFESCIENCES LTD (India), MATRIX PHARMACORP PRIVATE LTD (India), Piramal Pharma Limited (India), TAPI NL BV (Netherlands), ALIVUS LIFE SCIENCES LTD (India) and DASAMI LAB PRIVATE LTD (India), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Verapamil Hydrochloride Drug Master Files are active?

Abbott Laboratories (DMF 7000), Aurore Life Sciences (DMF 34043), COHANCE LIFESCIENCES LTD (DMF 34341), MATRIX PHARMACORP PRIVATE LTD (DMF 32293), Piramal Pharma Limited (DMF 16605), TAPI NL BV (DMF 8671), ALIVUS LIFE SCIENCES LTD (DMF 35691) and DASAMI LAB PRIVATE LTD (DMF 36808) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Verapamil Hydrochloride records mean?

10 organisations have only inactive Type II DMFs for Verapamil Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Verapamil Hydrochloride have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Verapamil Hydrochloride on the EDQM register, including AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), ASSURGEN PHARMA PRIVATE LIMITED Visakhapatnam (IN), PIRAMAL PHARMA LIMITED Digwal Village (IN), TAPI NL B.V. Amsterdam (NL) and COHANCE LIFESCIENCES LIMITED Hyderabad (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Verapamil Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Verapamil Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.